Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19126073 | 0.98 | ALDH1A1 (0.62) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL23706449 | 0.98 | ALDH1A1 (0.62) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL6037335 | 0.98 | ALDH1A1 (0.62) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL23706414 | 0.98 | ALDH1A1 (0.62) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL23706431 | 0.98 | ALDH1A1 (0.62) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL23706427 | 0.98 | ALDH1A1 (0.62) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL23706422 | 0.98 | ALDH1A1 (0.62) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL23706439 | 0.98 | ALDH1A1 (0.62) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL23706405 | 0.98 | ALDH1A1 (0.62) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL19124679 | 0.98 | ALDH1A1 (0.62) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020127330-A1 | Organic-inorganic hybrid polymer and method of making same | JIN DAN L (US) | 2002-09-12 | — | — | US | claimed |
| US-20010036554-A1 | Organic-incorganic hybrid polymer and method of making same | NANOFILM LTD | 2001-11-01 | — | — | US | claimed |
| EP-1136520-A2 | Organic- inorganic hybrid polymer and method of making the same | nanoFILM, Ltd. (US) | 2001-09-26 | — | — | EP | claimed |
| WO-2026105755-A1 | ANTITHROMBOTIC COATING MATERIAL, MEDICAL DEVICE, RESEARCH INSTRUMENT, METHODS FOR PRODUCING MEDICAL DEVICE AND RESEARCH INSTRUMENT, AND ADSORPTION SUPPRESSION METHOD | JSR株式会社 | 2026-05-21 | — | — | WO | disclosed |
| US-20260015646-A1 | ENZYME ELECTRODE, METHOD FOR PRODUCING ENZYME ELECTRODE, BIOSENSOR, AND BIO BATTERY | MURATA MANUFACTURING CO (JP) | 2026-01-15 | — | — | US | disclosed |
| CN-120059762-A | Liquid crystal aligning agent for forming weak anchor film, method for producing liquid crystal aligning film, and method for producing liquid crystal element | JSR株式会社 | 2025-05-30 | — | — | CN | disclosed |
| WO-2024209808-A1 | ENZYME ELECTRODE, METHOD FOR PRODUCING ENZYME ELECTRODE, BIOSENSOR, AND BIOBATTERY | 株式会社村田製作所 | 2024-10-10 | — | — | WO | disclosed |
| CN-118530734-A | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, polymer, and compound | JSR株式会社 | 2024-08-23 | — | — | CN | disclosed |
| CN-115003759-B | Resin composition, method for producing same, and multicomponent curable resin composition | 株式会社钟化 | 2023-12-01 | — | — | CN | disclosed |
| CN-116917368-A | Curable resin composition and use thereof | 株式会社钟化 | 2023-10-20 | — | — | CN | disclosed |
| CN-112210390-B | Liquid crystal aligning agent, liquid crystal alignment film, method for producing liquid crystal alignment film, liquid crystal display element, polymer, and compound | JSR株式会社 | 2023-08-08 | — | — | CN | disclosed |
| US-6844066-B2 | Superabsorbent cellulosic fiber and method of making same | RAYONIER PRODUCTS AND FINANCIAL SERVICES COMPANY (US) | 2005-01-18 | — | — | US | disclosed |
| WO-2004103412-A2 | SUPERABSORBENT CELLULOSIC FIBER AND METHOD OF MAKING SAME | RAYONIER PRODUCTS AND FINANCIAL SERVICES COMPANY (US) | 2004-12-02 | — | — | WO | disclosed |
| US-20040234760-A1 | SUPERABSORBENT CELLULOSIC FIBER AND METHOD OF MAKING SAME | RAYONIER PRODUCTS AND FINANCIAL SERVICES COMPANY | 2004-11-25 | — | — | US | disclosed |
| US-6607590-B2 | Clear protective thin film | NANOFILM, LTD. | 2003-08-19 | — | — | US | disclosed |
| US-6451420-B1 | ORGANIC POLYMER AND SILICA MOLECULES CHEMICALLY BONDED TOGETHER BY COVALENT BONDS, POLYMERIZED PRODUCT OF OLIGOMERS FROM HYDROLYSIS OF TETRAALKYL SILICATE, EPOXYALKYLALKOXY SILANES, ACRYLOXYALKYLALKOXY;LENSES | NANOFILM, LTD. | 2002-09-17 | — | — | US | disclosed |
| US-20020127330-A1 | Organic-inorganic hybrid polymer and method of making same | JIN DAN L (US) | 2002-09-12 | — | — | US | disclosed |
| US-20010036554-A1 | Organic-incorganic hybrid polymer and method of making same | NANOFILM LTD | 2001-11-01 | — | — | US | disclosed |
| EP-1136520-A2 | Organic- inorganic hybrid polymer and method of making the same | nanoFILM, Ltd. (US) | 2001-09-26 | — | — | EP | disclosed |
| US-5093389-A | Epoxy-Terminated Polysiloxane, Silanol-Terminated Polysiloxane Aminoxysilicon Compound | TOSHIBA SILICONE CO., LTD. (JP) | 1992-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015646-A1 | ENZYME ELECTRODE, METHOD FOR PRODUCING ENZYME ELECTRODE, BIOSENSOR, AND BIO BATTERY | SORD, NQO1, PDHB | TSHR 3339/4885ALDH1A1 92/4885TDP1 1919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.